In breast cancers, ADAM12 is selectively up-regulated in the claudin-low subtype of tumors [40], which have aggressive characteristics, molecular signatures of epithelial-to-mesenchymal transition, and are enriched in gene signatures of breast tumor-initiating cells [41]. This evidence concerns the gene ADAM12 and breast carcinoma.